Nilsson K - Search Results

1

IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.

Strömberg T, Ekman S, Girnita L, Dimberg LY, Larsson O, Axelson M, Lennartsson J, Hellman U, Carlson K, Osterborg A, Vanderkerken K, Nilsson K, Jernberg-Wiklund H. Strömberg T, et al. Among authors: nilsson k. Blood. 2006 Jan 15;107(2):669-78. doi: 10.1182/blood-2005-01-0306. Epub 2005 Sep 15. Blood. 2006. PMID: 16166596 Free article.

2

Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line.

Jernberg-Wiklund H, Pettersson M, Larsson LG, Anton R, Nilsson K. Jernberg-Wiklund H, et al. Among authors: nilsson k. Int J Cancer. 1992 Apr 22;51(1):116-23. doi: 10.1002/ijc.2910510121. Int J Cancer. 1992. PMID: 1563831

3

Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop.

Jernberg-Wiklund H, Pettersson M, Carlsson M, Nilsson K. Jernberg-Wiklund H, et al. Among authors: nilsson k. Leukemia. 1992 Apr;6(4):310-8. Leukemia. 1992. PMID: 1588793

4

Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.

Jernberg H, Pettersson M, Kishimoto T, Nilsson K. Jernberg H, et al. Among authors: nilsson k. Leukemia. 1991 Mar;5(3):255-65. Leukemia. 1991. PMID: 1707469

5

Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells.

Pettersson M, Jernberg-Wiklund H, Larsson LG, Sundström C, Givol I, Tsujimoto Y, Nilsson K. Pettersson M, et al. Among authors: nilsson k. Blood. 1992 Jan 15;79(2):495-502. Blood. 1992. PMID: 1730093 Free article.

6

Recombinant interferon-gamma inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitro.

Jernberg-Wiklund H, Pettersson M, Nilsson K. Jernberg-Wiklund H, et al. Among authors: nilsson k. Eur J Haematol. 1991 Apr;46(4):231-9. doi: 10.1111/j.1600-0609.1991.tb00546.x. Eur J Haematol. 1991. PMID: 1826658

7

Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells.

Larsson LG, Schena M, Carlsson M, Sällström J, Nilsson K. Larsson LG, et al. Among authors: nilsson k. Blood. 1991 Mar 1;77(5):1025-32. Blood. 1991. PMID: 1899807 Free article.

8

T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease.

Tötterman TH, Carlsson M, Simonsson B, Bengtsson M, Nilsson K. Tötterman TH, et al. Among authors: nilsson k. Blood. 1989 Aug 1;74(2):786-92. Blood. 1989. PMID: 2787679 Free article.

9

Cell cycle progression of B-chronic lymphocytic leukemia cells induced to differentiate by TPA.

Carlsson M, Tötterman TH, Matsson P, Nilsson K. Carlsson M, et al. Among authors: nilsson k. Blood. 1988 Feb;71(2):415-21. Blood. 1988. PMID: 3257396 Free article.

10

The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines.

Pettersson M, Sundström C, Nilsson K, Larsson LG. Pettersson M, et al. Among authors: nilsson k. Blood. 1995 Oct 1;86(7):2747-53. Blood. 1995. PMID: 7670114 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,624 results

Search Page

Filters